Dacomitinib-13C-d3 - Request Quote
Dacomitinib-13C-d3
| SZ CAT No: | SZ-D071D04 |
| CAS No | NA |
| Mol.F. | C2313CH22D3ClFN5O2 |
| Mol.Wt. | 474.0 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dacomitinib-13C-d3 is chemically (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-(methoxy-13C-d3)quinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Dacomitinib-13C-d3 is supplied with detailed characterization data compliant with regulatory guideline. Dacomitinib-13C-d3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dacomitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Dacomitinib-13C-d3
Purchase Dacomitinib-13C-d3
Dacomitinib-13C-d3 suppliers
Dacomitinib-13C-d3 manufacturers
Dacomitinib-13C-d3 price
Order Dacomitinib-13C-d3
Enquire Dacomitinib-13C-d3
Dacomitinib-13C-d3 cost
Dacomitinib-13C-d3 Supplier
Dacomitinib-13C-d3 Distributor
Dacomitinib-13C-d3 for Method Validation
Dacomitinib Reference Standard
Dacomitinib-13C-d3 for ANDA Filing
Dacomitinib-13C-d3 for Forced Degradation Studies
Dacomitinib-13C-d3 Identification Standards
Dacomitinib-13C-d3 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.